Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Sep;33(3):503–513.

Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

S Limatibul, A Shore, H M Dosch, E W Gelfand
PMCID: PMC1537427  PMID: 310744

Abstract

The binding of unsensitized sheep erythrocytes is a characteristic of human thymus dependent T-lymphocytes. We have investigated the effect of theophylline on E-rosette formation using cells from normal individuals, and patients with immunodeficiency or acute lymphoblastic leukaemia, and have attempted to correlate the influence of the drug on distinct T-lymphocyte subpopulations. Three subpopulations of E-rosetting T-lymphocytes can be delineated: theophylline-sensitive T-cells which lose the capacity to form E-rosettes following treatment; theophylline-resistant T-cells which are unaffected by the drug; and theophylline-dependent cells which acquire the ability to form E-rosettes following incubation with theophylline. The action of theophylline was shown to be dose-dependent, temperature-dependent and reversible. Reversibility or re-expression of the receptor for sheep red cells could be blocked by the addition of puromycin. In peripheral blood, E-rosetting T-lymphocytes were roughly divided into two equal populations, one sensitive, the other resistant. Thymocytes were shown to be entirely theophylline-resistant, whereas a small population of cells in peripheral blood and bone marrow were induced to become E-rosetting in the presence of theophylline. Induction by theophylline may be effective at a distinct stage of precursor T-cell differentiation.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach J. F., Carnaud C. Thymic factors. Prog Allergy. 1976;21:342–408. doi: 10.1159/000399402. [DOI] [PubMed] [Google Scholar]
  2. Bach M. A. Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations. J Clin Invest. 1975 May;55(5):1074–1081. doi: 10.1172/JCI108008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boldt D. H., Armstrong J. P. Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides. J Clin Invest. 1976 Apr;57(4):1068–1078. doi: 10.1172/JCI108349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borella L., Sen L. E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells. J Immunol. 1975 Jan;114(1 Pt 1):187–190. [PubMed] [Google Scholar]
  5. Chechik B. E., Pyke K. W., Gelfand E. W. Human thymus/leukemia-associated antigen in normal and leukemic cells. Int J Cancer. 1976 Nov 15;18(5):551–556. doi: 10.1002/ijc.2910180502. [DOI] [PubMed] [Google Scholar]
  6. Chisari F. V., Edgington T. S. Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med. 1974 Oct 1;140(4):1122–1126. doi: 10.1084/jem.140.4.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coombs R. R., Gurner B. W., Wilson A. B., Holm G., Lindgren B. Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol. 1970;39(5-6):658–663. doi: 10.1159/000230390. [DOI] [PubMed] [Google Scholar]
  8. Dosch H-M, Gelfand E. W. Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements. J Immunol. 1977 Jan;118(1):302–308. [PubMed] [Google Scholar]
  9. Galant S. P., Remo R. A. Beta-adrenergic inhibition of human T lymphocyte rosettes. J Immunol. 1975 Jan;114(1 Pt 2):512–513. [PubMed] [Google Scholar]
  10. Gelfand E. W., Chechik B. E. Editorial: Unmasking the heterogeneity of acute lymphoblastic leukemia. N Engl J Med. 1976 Jan 29;294(5):275–276. doi: 10.1056/NEJM197601292940511. [DOI] [PubMed] [Google Scholar]
  11. Gelfand E. W., Dosch H. M., Biggar W. D., Fox I. H. Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function. J Clin Invest. 1978 Apr;61(4):1071–1080. doi: 10.1172/JCI109006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gelfand E. W. Role of the C3 receptor in antibody-dependent cytotoxicity. Transplantation. 1976 Jan;21(1):73–75. doi: 10.1097/00007890-197601000-00014. [DOI] [PubMed] [Google Scholar]
  13. Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
  14. Grieco M. H., Siegel I., Goel Z. Modulation of human T lymphocyte rosette formation by autonomic agonists and cyclic nucleotides. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 2):149–159. doi: 10.1016/0091-6749(76)90150-0. [DOI] [PubMed] [Google Scholar]
  15. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kemp R. G., Duquesnoy R. J. Lymphoid cell adenylate cyclase activity after x-irradiation and cortisone treatment. J Immunol. 1975 Feb;114(2 Pt 1):660–664. [PubMed] [Google Scholar]
  17. Kitao T., Takeshita M., Hattori K. Studies on glycopeptide released by trypsin from sheep erythrocytes. J Immunol. 1976 Jul;117(1):310–312. [PubMed] [Google Scholar]
  18. Niaudet P., Beaurain G., Bach M. A. Differences in effect of isoproterenol stimulation on levels of cyclic AMP in human B and T lymphocytes. Eur J Immunol. 1976 Nov;6(11):834–836. doi: 10.1002/eji.1830061117. [DOI] [PubMed] [Google Scholar]
  19. Owen F. L., Fanger M. W. Studies on the human T-lymphocyte population. II. The use of a T-cell specific antibody in the partial isolation and characterization of the human lymphocyte receptor for sheep red blood cells. J Immunol. 1974 Oct;113(4):1138–1144. [PubMed] [Google Scholar]
  21. Pyke K. W., Dosch H., Ipp M. M., Gelfand E. W. Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease. N Engl J Med. 1975 Aug 28;293(9):424–428. doi: 10.1056/NEJM197508282930904. [DOI] [PubMed] [Google Scholar]
  22. Pyke K. W., Gelfand E. W. Detection of T-precursor cells in human bone marrow and foetal liver. Differentiation. 1976 Jun 4;5(2-3):189–191. doi: 10.1111/j.1432-0436.1976.tb00914.x. [DOI] [PubMed] [Google Scholar]
  23. Pyke K. W., Rawlings G. A., Gelfand E. W. Isolation and characterization of the sheep erythrocyte receptor in man. J Immunol. 1975 Jul;115(1):211–215. [PubMed] [Google Scholar]
  24. Scheid M. P., Hoffmann M. K., Komuro K., Hämmerling U., Abbott J., Boyse E. A., Cohen G. H., Hooper J. A., Schulof R. S., Goldstein A. L. Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med. 1973 Oct 1;138(4):1027–1032. doi: 10.1084/jem.138.4.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shore A., Dosch H., Gelfand E. W. Induction and separation of antigen-dependent T helper and T suppressor cells in man. Nature. 1978 Aug 10;274(5671):586–587. doi: 10.1038/274586a0. [DOI] [PubMed] [Google Scholar]
  26. Singh U., Owen J. J. Studies on the effect of various agents on the maturation of thymus stem cells. Eur J Immunol. 1975 Apr;5(4):286–288. doi: 10.1002/eji.1830050414. [DOI] [PubMed] [Google Scholar]
  27. Tsukimoto I., Wong K. Y., Lampkin B. C. Surface markers and prognostic factors in acute lymphoblastic leukemia. N Engl J Med. 1976 Jan 29;294(5):245–248. doi: 10.1056/NEJM197601292940503. [DOI] [PubMed] [Google Scholar]
  28. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Dicke KA Hooft J. I., van Bekkum D. W. The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Mouse spleen cell fractionation on a discontinuous albumin gradient. Transplantation. 1968 Jul;6(4):562–570. doi: 10.1097/00007890-196807000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES